This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Review -
Identification of epididymis-specific transcripts in the mouse
and rat by transcriptional profiling
Daniel S. Johnston1, Terry T.
Turner2,3, Joshua N. Finger1, Tracy L.
Owtscharuk1, Gregory S.
Kopf1, Scott A. Jelinsky4
1Contraception, Women's Health and Musculoskeletal Biology, Wyeth Research, Collegeville, PA 19426, USA
2Department of Urology and
3Cell Biology, University of Virginia Health Science System, Charlottesville, VA 22908, USA
4Biological Technologies, Molecular Profiling and Biomarker Discovery, Wyeth Research, Cambridge, MA 02140, USA
Abstract
As part of our efforts to identify novel contraceptive targets in the epididymis we performed transcriptional
profiling on each of the 10 and 19 segments of the mouse and rat epididymidis, respectively, using Affymetrix whole
genome microarrays. A total of 17 096 and 16 360 probe sets representing transcripts were identified as being
expressed in the segmented mouse and rat epididymal transcriptomes, respectively. Comparison of the expressed
murine transcripts against a mouse transcriptional profiling database derived from 22 other mouse tissues identified 77
transcripts that were expressed uniquely in the epididymis. The expression of these genes was further evaluated by
reverse transcription polymerase chain reaction (RT-PCR) analysis of RNA from 21 mouse tissues. RT-PCR analysis
confirmed epididymis-specific expression of Defensin Beta 13 and identified two additional genes with expression
restricted only to the epididymis and testis. Comparison of the 16 360 expressed transcripts in the rat epididymis with
data of 21 other tissues from a rat transcriptional profiling database identified 110 transcripts specific for the epididymis.
Sixty-two of these transcripts were further investigated by qPCR analysis. Only Defensin 22 (E3 epididymal protein)
was shown to be completely specific for the epididymis. In addition, 14 transcripts showed more than 100-fold
selective expression in the epididymis. The products of these genes might play important roles in epididymal and/or
sperm function and further investigation and validation as contraceptive targets are warranted. The results of the
studies described in this report are available at the Mammalian Reproductive Genetics (MRG) Database
(http://mrg.genetics.washington.edu/). (Asian J Androl 2007 July; 9: 522_527)
Keywords: mouse; rat; epididymis; transcriptional profiling; contraception; microarray; epididymis-specific; epididymis-selective
Correspondence to: Dr Daniel S. Johnston, Contraception, Women's Health and Musculoskeletal Biology, Wyeth Research, 500 Arcola Rd,
N2312 Collegeville, PA 19426, USA.
Tel: +1-484-865-2050 Fax: +1-484-865-9367
E-mail: johnstd2@wyeth.com
DOI: 10.1111/j.1745-7262.2007.00317.x
1 The epididymis as a target for contraception
Non-hormonal approaches to achieving contraception represent an innovative strategy for the development of
novel contraceptive therapeutics. The strategy is designed to identify specific gene products associated with the
reproductive tissues that mediate physiological processes required for the production of a mature gamete. In men, the
goal is to inhibit successful sperm production or maturation. The concept of post-testicular maturation of
spermatozoa as a target for male contraception is well established [1_3]. Sperm acquire progressive motility and the ability to
undergo capacitation during transit through the epididymis. These changes are a result of, in part, changes in the
composition of the epididymal luminal fluid microenvironment. Inhibition of
these post-testicular maturational events in sperm by modulating the function of specific proteins associated with the epididymis represents an attractive option
of contraception intervention [4, 5]. An advantage of targeting the epididymis through a non-hormonal approach is
that normal male endocrine function is unlikely to be
affected. This would preclude targeting the process of
spermatogenesis, thus avoiding potential issues with
aneuploidy. Moreover, reversibility of the contraceptive
effect would be rapid owing to the lack of a latency
period seen with strategies targeting the processes of
spermatogenesis.
As contraceptives are frequently given to healthy
people for long periods of time, it is also essential that
contraceptive drugs do not have significant side-effects.
One way to minimize any potential off-target, drug
profile is to focus on targets that are either unique to, or
highly selective for, the reproductive tract. To this end,
a large-scale segmental transcriptional profiling of both
mouse and rat epididymides using commercial whole
genome microarrays was performed. The data were
compared to those from a large in-house database of other
tissues derived from the same platform and generated
with exactly the same protocol. Those putative
epididymis-specific transcripts were investigated further using
more sensitive amplification-based technologies.
2 Segmental profiling of the rat and murine
epididymal transcriptomes
To date, numerous strategies for identifying novel
epididymis-specific transcripts or proteins have been used,
including micro-arrays [6_8], proteomics [9] and signal
sequence traps (Johnston, unpublished data). As part of
our effort to identify novel epididymis-based
contraceptive targets, we undertook a strategy to catalogue the
mouse and rat epididymis transcriptomes at the highest
possible resolution in a manner that would allow us to
rapidly compare the expressed transcripts with large
multi-tissue databases in order to identify novel
epididymis-specific transcripts.
Most of the published reports on transcriptional
profiling of the epididymis have used epididymal tissue
dissected into conventional caput, corpus, cauda regions
[8] or slightly more refined regions, such as the initial
segment (in the rat) [6]. In describing the localization of
epididymal gene expression or gene products, these
regions have also been described in greater detail (e.g.
proximal-, mid- or distal-caput). At the time we were
initiating our studies, one of us (Terry T. Turner), had
begun investigating the biological role of epididymal
segmentation in the mouse [10] and had demonstrated the
ability to micro-dissect the caput region reproducibly.
As it had become increasingly apparent from the
literature that many gene expression and protein localizations
within these regions are restricted to one or more
segments, we hypothesized that it would be possible and
beneficial to micro-dissect out all of the segments of the
mouse epididymis and subject each of these segments to
transcriptional profiling using genome-wide arrays. It
was felt that this strategy would provide a high
resolution cataloging of the mouse epididymal transcriptome
and assist in the identification and characterization of
putative targets. Complete segmentation of C57BL/6 mouse
epididymidis reproducibly identified 10 distinct
epididymal segments (Figure 1A) [11]. The expression profiles
and several analyses of these data have been reported
[11].
After completing the study in the mouse, several
factors prompted us to use this strategy to investigate the
segmented transcriptome of the Sprague-Dawley rat epididymis.
First, this approach would help to identify additional
contraceptive targets. Second, the rat is the most commonly
used animal model for studies of the epididymis. Third, this
species is a frequently used model within the
pharmaceutical industry for efficacy and toxicology studies and we
recognized that data from these studies would be important for
planning and interpreting such studies. Fourth, we had
established a large-scale transcriptional profiling effort of the
entire male rat reproductive tract and we were confident
that having the same high-resolution view of the rat
epididymal transcriptome would ultimately be beneficial to our
future efforts. Complete microdissection of
Sprague-Dawley epididymides reproducibly identified 19 distinct
epididymal segments (Figure 1B). Analysis of these data
have been reported [12].
Importantly, the two profiling efforts described above
have considerable importance beyond the identification
of novel targets. The data from these studies provide a
high resolution, physiologically relevant index of gene
expression along the full length of mouse and rat epididymides, elucidate the epididymal expression of
individual genes [11, 12], gene families [11, 12] and genes
that comprise biological pathways, and allow
comparison of gene expression between the two species [12].
Interested readers are encouraged to view these primary
references and to utilize the data available on the public
database (Mammalian Reproductive Genetics, MRG). The present report will provide novel data about
epididymis-specific genes identified from our profiling efforts
and will characterize the expression profiles of those
transcripts.
3 Identification of epididymis-specific transcripts
in the mouse
The 17 096 transcripts expressed in the mouse
epididymis were compared to an internal database of 22 mouse
transcriptional profiling data to identify transcripts that
were detected only in the samples of RNA from the mouse
epididymis. The criteria to be considered "epididymis
specific" are described in Johnston et al.
[11]. Briefly, the transcript had to be called "present" in at least 67%
of the samples in at least one epididymal segment with a
mean expression of > 50 signal units and the transcript
had never to be called "present" in any of the samples
from the other 22 tissues. The data for each tissue were
comprised of between 3 and 12 replicates. RNA from
the following tissues were used for comparison: adrenal,
bladder, brain, colon, embryo, eye, heart, kidney, liver, lung,
lymph node, ovary, pituitary, prostate, salivary gland, small
intestine, spleen, stomach, testis, thymus, uterus and vagina.
Seventy-seven transcripts met the criteria for
epididymal specificity, including a number of genes historically
studied in the epididymis, such as lipocalin 5, glutathione
peroxidase 5 and Adam 7. Interestingly, a large number of
transcripts corresponding to β-defensin genes were also
identified, including β-defensins 2, 9, 11, 13 and 15. The
analysis also identified transcripts of several
uncharacterized or hypothetical genes, including Hypothetical
Protein A230091H23, RIKEN cDNA 9230116B18 Gene and
cDNA Sequence AJ554213. A list of 49
epididymis-specific probe sets is provided in Johnston
et al. [11]. The identity of the remaining 28 probe sets, so far as they
were known, is provided in Table 1. The identity of all
77 probe sets can be found on the MRG database by
selecting "Download Database" and selecting the link for
"Datasets from Wyeth Research".
We wished to confirm and characterize further the
expression of transcripts identified as being
epididymis-specific from the above analysis. In addition, we
decided to increase the number of probe sets under
evaluation by investigating both epididymis-specific probe sets
(described above) and epididymis-selective probe sets.
The criteria for epididymal-selective probe sets is
described in Johnston et al. [11]. Briefly, for a transcript
to be epididymal-selective, it had to present in 66% of
the samples in at least one segment with a mean
expression of > 50 signal units and it had to have a signal value
> 3-fold higher than all of the other 21 normal tissues.
As these criteria were less stringent, all of the 77
epididymis-specific transcripts met the criteria for being
epididymis-selective. This resulted in the identification of
307 murine epididymis-selective transcripts. The
identity of the epididymis-selective transcripts is available on
the MRG database by selecting "Download Database" and
selecting the link for "Datasets from Wyeth Research".
The tissue expression profile of each of the 307 transcripts
was visually inspected to identify those transcripts that
had high signal values in other tissues and these probe sets
were excluded. Approximately 130 appeared to show high
selectivity in the epididymis and were selected for further
analysis.
The tissue distribution of these transcripts was
analyzed by RT-PCR analysis of RNA from a total of 21
normal tissues, including the epididymis. The tissues
used in these analyses were ovary, epididymis, testis,
prostate, embryo, muscle, kidney, liver, placenta, heart,
intestine, lung, brain, pancreas, stomach, hypothalamus,
spleen, thymus, uterus, pituitary and colon. This
analysis showed that only one transcript corresponding to
Defensin β13 was expressed solely in the epididymis
(Figure 2). Two additional transcripts corresponding to
Eppin and RIKEN cDNA 9230105I15 gene each had strong expression in the epididymal samples and weak
expression in the testis (data not shown).
4 Identification of epididymal-specific transcripts
in the rat
After completing the analysis of epididymis-specific
transcripts in the mouse, a similar strategy was used to
identify additional epididymis-specific transcripts in the
rat. To this end, the 16 360 transcripts expressed in the
rat epididymis were compared with a Wyeth Research
database of rat profiling data from 22 distinct normal tissues.
The tissues used for comparison were similar to those
used for the mouse and are listed in the Materials and
Methods of Jelinsky et al. [12]. The criterion for
epididymal specificity was effectively identical to that used
for the mouse and 110 transcripts met the criteria for
epididymal specificity. Among the 110 transcripts were
known "epididymis specific" genes, such as
Cystatin 11, Adam7 and LCN5. Many of the identified transcripts have
not been reported to be epididymis-specific, including
Adora1, Gdf15 and Kcng3, and their function in the
epididymis is not known. The complete list of probe sets has
been provided [12] and has been placed on the MRG.
We characterized the expression of the 110
epididymis-selective genes in 11 additional types of normal rat
tissue, including bone, bone marrow, cerebellum, hippocampus, hypothalamus, cartilage, esophagus, white
fat, meniscus, muscle and pancreas. We found that 48
transcripts were also expressed in at least one of these
additional 11 tissues. The tissue expression of the
remaining 62 transcripts was characterized by qPCR. Using
PrimerExpress (Applied Biosystems, Foster City, CA,
USA) transcript-specific primer/probe sets were
identified and cross-reactivity of each primer probe set
sequence was evaluated using the BLAST algorithm and
determined to be specific for each qualifier. Twelve point
standard curves were generated for caput, corpus, and
cauda epididymidal total RNA and used to validate all 62
probe sets. One primer probe set failed to be validated
and was therefore eliminated from further analysis.
A panel of 28 tissues was evaluated, including 19
non-reproductive tissues and 9 male reproductive tissues. The
19 non-reproductive tissues were adipose tissue, adrenal
gland, bone, cerebellum, cerebrum, colon, heart, small
intestine, kidney, liver, lung, meniscus, pancreas, salivary
gland, skeletal muscle, spleen, stomach, synovium and
thymus. The nine male reproductive tissues were
bulbourethral gland, prostate, seminal vesicle, testis, vas
deferens, caput epididymidis, corpus epididymidis, cauda
epididymidis and whole epididymis. All tissues were
dissected in triplicate from littermates and frozen in liquid
nitrogen. Total RNA was isolated using CsCl2
centrifugation followed by DNAase treatment on QIAgen RNAeasy
columns and expression of each of the 61 transcripts in
the 28 tissues was determined as previously described [12].
In total, 14 transcripts were found to have
>100-fold higher expression in epididymal tissue than any other
non-reproductive tissue and 5 were > 10 000-fold higher in
the epididymis tissue than any other non-reproductive
tissue. These 5 transcripts included ERABP (> 30 000),
Defβ22 (> 28 000), Spag 11 (> 20 000), Transmembrane
Epididymal Protein 1 (> 16 000) and cystatin 8 (> 11 000).
These genes that are so highly enriched may be critical
for epididymal function. Davies et al.
[13] reported that disruption of mouse HE6 (Transmembrane Epididymal
Protein 1) downregulates genes specific to the caput
epididymidis and results in male infertility, indicating that
this approach is valid. Other epididymis-specific genes,
such as beta-galactosidase-like protein, ribonuclease 12
and indoleamine-2,3-dioxygenase have not been implicated
in male reproduction, but might provide novel putative
targets for male contraception. A representative electronic
distribution and qPCR analysis for transmembrane
epididymal protein 1 is shown in Figure 3. The
identities of all 14 genes and the qPCR data have been placed on the
MRG database and can be found as described above.
5 Conclusion
The epididymis-selective genes described in this
manuscript were identified using sensitive technologies
that are amenable to high volume screening. These data
should be viewed in the context of the sensitivity of the
microarray technology and amplification procedures used
to determine their expression and the panel of tissues
used for analysis. Evaluation of these transcripts using
additional tissues and/or more sensitive assays could
alter their designation as epididymis selective/specific. This
analysis provides an important dataset of genes and gene
products to be further evaluated in order to understand
the role they might play in epididymal function. It is the
authors' hope that this resource will assist interested
investigators to develop novel hypothesis about the
cellular and molecular biology of the epididymis and, ultimately,
lead to new insights into epididymal function.
References
1 Turner TT, Johnston DS, Jelinsky SA. Epididymal genomics and
the search for a male contraceptive. Mol Cell Endocrinol 2006;
250: 178_83.
2 Gottwald U, Davies B, Fritsch M, Habenicht UF. New approaches
for male fertility control: HE6 as an example of a putative
target. Mol Cell Endocrinol 2006; 250: 49_57.
3 O'Rand MG, Widgren EE, Sivashanmugam P, Richardson RT, Hall
SH, French FS, et al. Reversible immunocontraception in male
monkeys immunized with Eppin. Science 2004; 306: 1189_90.
4 Lyttle CR, Kopf GS. Status and future direction of male
contraceptive development. Curr Opin Pharmacol 2003; 3: 667_71.
5 Johnston DS, Bai Y, Kopf GS. Utilization of human genome
databases in strategies for contraceptive development. In: Turner
TT, Hinton BT, editors. Epididymis III: The Third
International Conference on the Epididymis. Charlottesville: The Van
Doren Company; 2002: 256_70.
6 Hsia N, Cornwall GA. DNA microarray analysis of
region-specific gene expression in the mouse epididymis. Biol Reprod
2004; 70: 448_57.
7 Jervis KM, Robaire B. Dynamic changes in gene expression
along the rat epididymis. Biol Reprod 2001; 65: 696_703.
8 Chauvin TR, Griswold MD. Androgen-regulated genes in the
murine epididymis. Biol Reprod 2004; 71: 560_9.
9 Dacheux JL, Belghazi M, Lanson Y, Dacheux F. Human
epididymal secretome and proteome. Mol Cell Endocrinol 2006; 250:
36_42.
10 Turner TT, Bomgardner D, Jacobs JP, Nguyen QA. Association
of segmentation of the epididymal interstitium with segmented
tubule function in rats and mice. Reproduction 2003; 125:
871_8.
11 Johnston DS, Jelinsky SA, Bang HJ, Dicandeloro P, Wilson E,
Kopf GS, et al. The mouse epididymal transcriptome:
transcriptional profiling of segmental gene expression in the epididymis.
Biol Reprod 2005; 73: 404_13.
12 Jelinsky SA, Turner TT, Bang HJ, Finger JN, Solarz MK, Wilson
E, et al. The rat epididymal transcriptome: comparison of
segmental gene expression in the rat and mouse epididymides. Biol
Reprod 2007; 76: 561_70.
13 Davies B, Behnen M, Cappallo-Obermann H, Spiess AN, Theuring
F, Kirchhoff C. Novel epididymis-specific mRNAs downregulated
by HE6/Gpr64 receptor gene disruption. Mol Reprod Develop
2007; 74: 539_53. |